Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula

L Zhao, H Zhang, N Li, J Chen, H Xu, Y Wang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Network pharmacology is a new discipline based on
systems biology theory, biological system network analysis, and multi-target drug molecule …

Renal compression in heart failure: the renal tamponade hypothesis

EM Boorsma, JM Ter Maaten, AA Voors… - Heart Failure, 2022 - jacc.org
Renal dysfunction is one of the strongest predictors of outcome in heart failure. Several
studies have revealed that both reduced perfusion and increased congestion (and central …

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial

J Biegus, AA Voors, SP Collins… - European Heart …, 2023 - academic.oup.com
Aims Effective and safe decongestion remains a major goal for optimal management of
patients with acute heart failure (AHF). The effects of the sodium–glucose cotransporter 2 …

Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European …

J Núñez, R de la Espriella, P Rossignol… - European Journal of …, 2022 - Wiley Online Library
Congestion is a cardinal sign of heart failure (HF). In the past, it was seen as a
homogeneous epiphenomenon that identified patients with advanced HF. However, current …

Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives

F Husain‐Syed, HJ Gröne, B Assmus, P Bauer… - ESC heart …, 2021 - Wiley Online Library
Venous congestion has emerged as an important cause of renal dysfunction in patients with
cardiorenal syndrome. However, only limited progress has been made in differentiating this …

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

EM Boorsma, JC Beusekamp… - European journal of …, 2021 - Wiley Online Library
Aims Sodium–glucose co‐transporter 2 (SGLT2) inhibitors improve clinical outcome in
patients with heart failure (HF), but the mechanisms behind their beneficial effects are not yet …

Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF …

J Jensen, M Omar, C Kistorp, C Tuxen… - The lancet Diabetes & …, 2021 - thelancet.com
Background SGLT2 inhibitors are a promising treatment option in patients with heart failure
and reduced ejection fraction. We aimed to investigate the effects of empagliflozin on …

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial

J Tromp, P Ponikowski, A Salsali… - European journal of …, 2021 - Wiley Online Library
Aims Treatment with sodium–glucose co‐transporter 2 (SGLT2) inhibitors improves
outcomes in patients with chronic heart failure (HF) with reduced ejection fraction. There is …

Prevalence of systemic venous congestion assessed by Venous Excess Ultrasound Grading System (VExUS) and association with acute kidney injury in a general …

S Andrei, PA Bahr, M Nguyen, B Bouhemad, PG Guinot - Critical Care, 2023 - Springer
Background The importance of assessing venous congestion in ICU patients is widely
acknowledged, but its study is hampered by the lack of a practical evaluation tool. The …

Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review

M Itkin, SG Rockson, D Burkhoff - Journal of the American College of …, 2021 - jacc.org
The removal of interstitial fluid from the tissues is performed exclusively by the lymphatic
system. Tissue edema in congestive heart failure occurs only when the lymphatic system …